eFFECTOR Therapeutics, Inc. - Equity Warrant
US ˙ OTCPK

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Peter Svennilson. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Peter Svennilson telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:RAPT / RAPT Therapeutics, Inc. 10% Owner 0
US:NGM / NGM Biopharmaceuticals, Inc. 10% Owner 1,000
US:ORIC / ORIC Pharmaceuticals, Inc. 10% Owner 74
US:EFTR / eFFECTOR Therapeutics, Inc. 10% Owner 4,309,329
US:NRIX / Nurix Therapeutics, Inc. 10% Owner 48,406
US:RVMD / Revolution Medicines, Inc. Director 1,775,236
10% Owner 99,155
US:GRTS / Gritstone bio, Inc. Director, 10% Owner 8,570
US:IMDZ / Immune Design Corp. 10% Owner 0
US:RCUS / Arcus Biosciences, Inc. 10% Owner 0
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Peter Svennilson. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant Insider Trades
Jualan Orang Dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant Insider Trades
Pembelian Orang Dalam NRIX / Nurix Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Jualan Orang Dalam NRIX / Nurix Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam ORIC / ORIC Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

ORIC / ORIC Pharmaceuticals, Inc. Insider Trades
Jualan Orang Dalam ORIC / ORIC Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

ORIC / ORIC Pharmaceuticals, Inc. Insider Trades
Pembelian Orang Dalam RAPT / RAPT Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2022-05-24 RAPT COLUMN GROUP II, LP 15,776 12.0021 1,972 96.0168 189,345 283 30.8000 -128,607 -67.92
2022-05-24 RAPT COLUMN GROUP II, LP 538 12.0021 67 96.0168 6,457
2022-05-23 RAPT COLUMN GROUP II, LP 9,898 12.4993 1,237 99.9944 123,718
2022-05-23 RAPT COLUMN GROUP II, LP 338 12.4993 42 99.9944 4,225
2019-11-04 RAPT COLUMN GROUP II, LP 625,000 12.0000 78,125 96.0000 7,500,000

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RAPT / RAPT Therapeutics, Inc. Insider Trades
Jualan Orang Dalam RAPT / RAPT Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2021-09-27 RAPT COLUMN GROUP II, LP 7,500 34.4808 938 275.8464 258,606 224 10.2600 -248,992 -96.28
2021-09-27 RAPT COLUMN GROUP II, LP 1,114 34.9650 139 279.7200 38,951
2021-09-27 RAPT COLUMN GROUP II, LP 625 34.9446 78 279.5568 21,840
2021-09-15 RAPT COLUMN GROUP II, LP 11,476 37.2138 1,434 297.7104 427,066
2021-09-15 RAPT COLUMN GROUP II, LP 4,400 37.6732 550 301.3856 165,762
2021-09-15 RAPT COLUMN GROUP II, LP 12,939 37.2234 1,617 297.7872 481,634
2021-09-15 RAPT COLUMN GROUP II, LP 4,720 37.7028 590 301.6224 177,957
2021-09-14 RAPT COLUMN GROUP II, LP 1,400 35.7071 175 285.6568 49,990
2021-09-14 RAPT COLUMN GROUP II, LP 29,634 36.7869 3,704 294.2952 1,090,143
2021-09-14 RAPT COLUMN GROUP II, LP 25,351 37.2705 3,169 298.1640 944,844
2021-09-14 RAPT COLUMN GROUP II, LP 1,700 35.7732 212 286.1856 60,814
2021-09-14 RAPT COLUMN GROUP II, LP 42,151 36.9160 5,269 295.3280 1,556,046
2021-09-14 RAPT COLUMN GROUP II, LP 10,807 37.3148 1,351 298.5184 403,261
2021-09-14 RAPT COLUMN GROUP II, LP 1,496 35.7466 187 285.9728 53,477
2021-09-14 RAPT COLUMN GROUP II, LP 32,211 36.8528 4,026 294.8224 1,187,066
2021-09-14 RAPT COLUMN GROUP II, LP 2,926 37.3062 366 298.4496 109,158
2021-09-13 RAPT COLUMN GROUP II, LP 4,803 35.2506 600 282.0048 169,309
2021-09-13 RAPT COLUMN GROUP II, LP 4,726 35.2713 591 282.1704 166,692
2021-09-13 RAPT COLUMN GROUP II, LP 4,788 35.2845 598 282.2760 168,942
2021-09-10 RAPT COLUMN GROUP II, LP 7,187 35.1941 898 281.5528 252,940
2021-09-10 RAPT COLUMN GROUP II, LP 7,320 35.1875 915 281.5000 257,572
2021-09-10 RAPT COLUMN GROUP II, LP 7,231 35.1949 904 281.5592 254,494
2021-09-02 RAPT COLUMN GROUP II, LP 18,545 35.4318 2,318 283.4544 657,083
2021-09-02 RAPT COLUMN GROUP II, LP 18,556 35.4316 2,320 283.4528 657,469
2021-09-01 RAPT COLUMN GROUP II, LP 6,904 35.0163 863 280.1304 241,753
2021-09-01 RAPT COLUMN GROUP II, LP 8,976 35.3915 1,122 283.1320 317,674
2021-09-01 RAPT COLUMN GROUP II, LP 8,805 35.0575 1,101 280.4600 308,681
2021-09-01 RAPT COLUMN GROUP II, LP 7,064 35.4592 883 283.6736 250,484
2021-08-24 RAPT COLUMN GROUP II, LP 2,300 30.8057 288 246.4456 70,853
2021-08-24 RAPT COLUMN GROUP II, LP 3,486 31.7575 436 254.0600 110,707
2021-08-24 RAPT COLUMN GROUP II, LP 2,200 30.7909 275 246.3272 67,740
2021-08-24 RAPT COLUMN GROUP II, LP 3,463 31.7581 433 254.0648 109,978
2021-08-24 RAPT COLUMN GROUP II, LP 4,318 30.9408 540 247.5264 133,602
2021-08-24 RAPT COLUMN GROUP II, LP 7,100 31.7651 888 254.1208 225,532
2021-08-23 RAPT COLUMN GROUP II, LP 7,605 30.9267 951 247.4136 235,198
2021-08-23 RAPT COLUMN GROUP II, LP 12,969 31.4113 1,621 251.2904 407,373
2021-08-23 RAPT COLUMN GROUP II, LP 2,200 32.3490 275 258.7920 71,168
2021-08-23 RAPT COLUMN GROUP II, LP 7,278 30.9187 910 247.3496 225,026
2021-08-23 RAPT COLUMN GROUP II, LP 13,623 31.4035 1,703 251.2280 427,810
2021-08-23 RAPT COLUMN GROUP II, LP 2,007 32.3926 251 259.1408 65,012
2021-08-23 RAPT COLUMN GROUP II, LP 8,204 30.9429 1,026 247.5432 253,856
2021-08-23 RAPT COLUMN GROUP II, LP 12,354 31.4168 1,544 251.3344 388,123
2021-08-23 RAPT COLUMN GROUP II, LP 2,100 32.3831 262 259.0648 68,005
2021-08-20 RAPT COLUMN GROUP II, LP 1,440 30.0879 180 240.7032 43,327
2021-08-20 RAPT COLUMN GROUP II, LP 1,429 30.0802 179 240.6416 42,985
2021-08-20 RAPT COLUMN GROUP II, LP 1,670 30.0732 209 240.5856 50,222

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RAPT / RAPT Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam RCUS / Arcus Biosciences, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RCUS / Arcus Biosciences, Inc. Insider Trades
Jualan Orang Dalam RCUS / Arcus Biosciences, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RCUS / Arcus Biosciences, Inc. Insider Trades
Pembelian Orang Dalam RVMD / Revolution Medicines, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RVMD / Revolution Medicines, Inc. Insider Trades
Jualan Orang Dalam RVMD / Revolution Medicines, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

RVMD / Revolution Medicines, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Peter Svennilson seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2024-12-23 2024-12-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1,599,417 0 -100.00
2024-12-23 2024-12-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1,352,008 50,000 -96.43
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,000 1,000
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -44,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -15,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1,298,908 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1,298,908 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2,265,758 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -968,990 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -858,035 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -11,103,333 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -90,442 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2,650,177 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -949,862 0 -100.00
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,840 949,862 0.62 0.62 3,627 589,959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,791 944,022 1.81 0.71 11,880 667,896
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176,730 927,231 23.55 5.00 883,403 4,634,857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,542 750,501 1.02 5.00 37,707 3,752,205
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,900 742,959 1.35 5.00 49,494 3,714,349
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733,059 0.07 5.00 2,498 3,662,363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,639 732,559 5.42 5.00 188,105 3,661,037
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,378 694,920 0.78 4.95 26,603 3,437,491
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209,000 689,542 43.49 4.76 994,840 3,282,220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100,070 480,542 26.30 4.84 484,519 2,326,688
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380,472 0.08 4.98 1,493 1,893,495
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,330 380,172 1.15 5.00 21,646 1,900,518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,997 375,842 10.59 5.00 179,942 1,878,759
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,058 339,845 11.50 4.72 165,320 1,602,573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104,090 304,787 51.86 4.99 519,107 1,520,003
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76,877 200,697 62.09 4.86 373,638 975,428
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72,774 123,820 142.57 4.85 353,041 600,676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51,046 51,046 4.75 242,387 242,387
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,477 90,442 56.03 13.50 438,440 1,220,967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951,684 2,650,177 56.03 13.50 12,847,734 35,777,390
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,129 57,965 1.99 13.03 14,715 755,475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,071 1,698,493 1.99 13.03 431,024 22,136,969
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,036 56,836 5.64 13.45 40,834 764,444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88,964 1,665,422 5.64 13.45 1,196,566 22,399,926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,040 53,800 3.94 13.47 27,470 724,460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59,766 1,576,458 3.94 13.47 804,797 21,228,268
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51,760 0.17 13.45 1,197 696,239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,621 1,516,692 0.17 13.45 35,256 20,401,479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51,671 1.31 13.49 9,000 697,223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,534 1,514,071 1.31 13.49 263,582 20,430,117
2022-05-27 2022-05-25 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 63 42,189 0.15 12.45 785 525,460
2022-05-27 2022-05-25 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 1,837 1,236,261 0.15 12.45 22,880 15,397,507
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,429 51,004 2.88 13.43 19,198 685,234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41,863 1,494,537 2.88 13.43 562,425 20,078,955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49,575 1.20 13.37 7,860 662,719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,240 1,452,674 1.20 13.37 230,464 19,419,346
2022-05-25 2022-05-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 538 42,126 1.29 12.00 6,457 505,600
2022-05-25 2022-05-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 15,776 1,234,424 1.29 12.00 189,345 14,815,680
2022-05-25 2022-05-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 338 41,588 0.82 12.50 4,225 519,821
2022-05-25 2022-05-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 9,898 1,218,648 0.82 12.50 123,718 15,232,247
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48,987 1.30 13.48 8,464 660,227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18,406 1,435,434 1.30 13.48 248,069 19,346,205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48,359 1.43 13.25 9,040 640,984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,984 1,417,028 1.43 13.25 264,882 18,782,281
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,067 47,677 4.53 13.20 27,292 629,522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60,583 1,397,044 4.53 13.20 799,932 18,446,429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,939 45,610 6.89 13.42 39,433 611,954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86,110 1,336,461 6.89 13.42 1,155,346 17,931,431
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,094 42,671 2.63 12.90 14,114 550,520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,072 1,250,351 2.63 12.90 413,777 16,131,403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,269 41,577 11.44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125,096 1,218,279 11.44
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37,308 0.05 11.81 201 440,447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1,093,183 0.04 11.81 5,726 12,905,791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,728 37,291 7.89 11.62 31,702 433,362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79,945 1,092,698 7.89 11.62 929,049 12,698,353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34,563 0.26 11.85 1,043 409,478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,564 1,012,753 0.25 11.85 30,376 11,998,389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,657 34,475 8.35 11.23 29,827 387,009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77,866 1,010,189 8.35 11.23 874,108 11,340,180
2022-05-12 2022-05-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 41,250 41,250 10.67 440,199 440,199
2022-05-12 2022-05-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 1,208,750 1,208,750 10.67 12,899,176 12,899,176
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,032 31,818 3.35 11.36 11,727 361,567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,233 932,323 3.35 11.36 343,556 10,594,546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,745 30,786 9.79 10.79 29,627 332,270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80,430 902,090 9.79 10.79 868,073 9,736,167
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,791 28,041 239.89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579,910 821,660 239.88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,250 8,250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241,750 241,750
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other 74 74
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other 86,716 103,341 521.60
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other 86,716 103,341 521.60
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other -287,702 0 -100.00
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other 287,702 287,702
2021-11-16 2021-11-16 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
J - Other -1,200,000 3,568,181 -25.17
2021-11-16 2021-11-12 4 ORIC Oric Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -16,625 0 -100.00
2021-11-16 2021-11-12 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
M - Exercise 16,625 16,625 16.00 266,000 266,000
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 6,875 -8.33
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -1,114 1,115 -49.98
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -7,500 15,000 -33.33
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -625 0 -100.00 34.94 -21,840
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 625 625 19.30 12,062 12,062
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,114 0 -100.00 34.96 -38,951
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 1,114 1,114 22.20 24,731 24,731
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,500 0 -100.00 34.48 -258,606
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 7,500 7,500 28.27 212,025 212,025
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,720 0 -100.00 37.70 -177,957
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12,939 4,720 -73.27 37.22 -481,634 175,694
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,400 0 -100.00 37.67 -165,762
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -11,476 4,400 -72.29 37.21 -427,066 163,741
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,926 0 -100.00 37.31 -109,158
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -32,211 2,926 -91.67 36.85 -1,187,066 107,831
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,496 35,137 -4.08 35.75 -53,477 1,256,028
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -10,807 17,659 -37.96 37.31 -403,261 658,942
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -42,151 28,466 -59.69 36.92 -1,556,046 1,050,851
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,700 70,617 -2.35 35.77 -60,814 2,526,196
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -25,351 15,876 -61.49 37.27 -944,844 591,706
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -29,634 41,227 -41.82 36.79 -1,090,143 1,516,614
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,400 70,861 -1.94 35.71 -49,990 2,530,241
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,788 36,633 -11.56 35.28 -168,942 1,292,577
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,726 72,261 -6.14 35.27 -166,692 2,548,739
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,803 72,317 -6.23 35.25 -169,309 2,549,218
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,231 41,421 -14.86 35.19 -254,494 1,457,808
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,320 76,987 -8.68 35.19 -257,572 2,708,980
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,187 77,120 -8.52 35.19 -252,940 2,714,169
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 48,652 48,652
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 84,307 84,307
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 84,307 84,307
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 72 163 79.12
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -279,710 0 -100.00
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 279,710 279,710
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1,166,666 1,402,008 -45.42
2021-09-07 3 EFTR eFFECTOR Therapeutics, Inc.
Common Stock
4,309,329
2021-09-03 2021-09-02 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -18,556 0 -100.00 35.43 -657,469
2021-09-03 2021-09-02 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -18,545 0 -100.00 35.43 -657,083
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,064 18,556 -27.57 35.46 -250,484 657,981
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8,805 25,620 -25.58 35.06 -308,681 898,173
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8,976 18,545 -32.62 35.39 -317,674 656,335
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -6,904 27,521 -20.06 35.02 -241,753 963,684
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,100 0 -100.00 31.77 -225,532
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4,318 7,100 -37.82 30.94 -133,602 219,680
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -3,463 34,425 -9.14 31.76 -109,978 1,093,273
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,200 37,888 -5.49 30.79 -67,740 1,166,606
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -3,486 34,425 -9.20 31.76 -110,707 1,093,252
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,300 37,911 -5.72 30.81 -70,853 1,167,875
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,100 11,418 -15.53 32.38 -68,005 369,750
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12,354 13,518 -47.75 31.42 -388,123 424,692
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8,204 25,872 -24.08 30.94 -253,856 800,555
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,007 40,088 -4.77 32.39 -65,012 1,298,555
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -13,623 42,095 -24.45 31.40 -427,810 1,321,930
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,278 55,718 -11.55 30.92 -225,026 1,722,728
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2,200 40,211 -5.19 32.35 -71,168 1,300,786
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12,969 42,411 -23.42 31.41 -407,373 1,332,185
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7,605 55,380 -12.07 30.93 -235,198 1,712,721
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,670 34,076 -4.67 30.07 -50,222 1,024,774
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,429 62,996 -2.22 30.08 -42,985 1,894,932
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1,440 62,985 -2.24 30.09 -43,327 1,895,086
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 35,746 35,746
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 64,425 64,425
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 64,425 64,425
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 91 91
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -208,403 0 -100.00
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 208,403 208,403
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1,317,005 2,568,674 -33.89
2021-06-24 2021-05-28 4 RAPT RAPT Therapeutics, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2021-06-17 2021-06-16 4 ORIC Oric Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 16,625 16,625
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7,752 48,406 19.07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49,689 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49,689 49,689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1,000,000 989,000 -50.28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30,347 40,654 294.43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111,247 121,554 1,079.33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105,874 116,181 1,027.20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438,338 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438,338 438,338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2,000,000 1,394,333 -58.92
2021-04-28 2021-04-28 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -53 1,775,236 0.00 42.50 -2,252 75,447,530
2021-04-28 2021-04-28 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -47 1,571,963 0.00 42.50 -1,998 66,808,428
2021-04-28 2021-04-27 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -12,371 1,775,289 -0.69 42.65 -527,659 75,721,224
2021-04-28 2021-04-27 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -10,955 1,572,010 -0.69 42.65 -467,263 67,050,785
2021-04-28 2021-04-26 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -28,101 1,787,660 -1.55 42.85 -1,204,027 76,594,795
2021-04-28 2021-04-26 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -24,883 1,582,965 -1.55 42.85 -1,066,147 67,824,352
2021-04-12 2021-04-09 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -13,101 1,815,761 -0.72 43.83 -574,162 79,577,178
2021-04-12 2021-04-09 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -11,600 1,607,848 -0.72 43.83 -508,379 70,465,225
2021-04-12 2021-04-08 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -24,518 1,828,862 -1.32 44.80 -1,098,507 81,940,516
2021-04-12 2021-04-08 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -21,710 1,619,448 -1.32 44.80 -972,697 72,557,910
2021-04-07 2021-04-07 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -14,825 1,853,380 -0.79 45.60 -676,087 84,522,468
2021-04-07 2021-04-07 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -13,128 1,641,158 -0.79 45.60 -598,696 74,844,190
2021-04-07 2021-04-06 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -20,949 1,868,205 -1.11 48.06 -1,006,847 89,789,295
2021-04-07 2021-04-06 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -18,551 1,654,286 -1.11 48.06 -891,594 79,507,963
2021-04-07 2021-04-05 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -9,661 1,889,154 -0.51 46.65 -450,732 88,138,102
2021-04-07 2021-04-05 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale X -8,554 1,672,837 -0.51 46.65 -399,085 78,045,876
2021-04-02 2021-03-31 4 RAPT RAPT Therapeutics, Inc.
Stock Option (right to buy)
A - Award 2,229 2,229 15.70 34,996 34,996
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 99,155 -9.16 36.95 -369,503 3,663,807
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30,107 0 -100.00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30,107 2,584,957 1.18 1.55 46,666 4,006,683
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other 13,068 20,302 180.65
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other 46 46
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other -46,868 0 -100.00
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other 24,857 46,868 112.93
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other -530,365 1,898,815 -21.83
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other 22,011 22,011
2020-12-11 2020-12-09 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other -469,635 1,681,391 -21.83
2020-11-18 2020-11-16 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale -1,075,133 2,429,180 -30.68 36.40 -39,134,841 88,422,152
2020-11-18 2020-11-16 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale -952,023 2,151,026 -30.68 36.40 -34,653,637 78,297,346
2020-09-22 2020-09-22 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -608,000 3,835,679 -13.68 30.85 -18,756,800 118,330,697
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27,595 1,827,025 1.53 17.67 487,604 32,283,532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,494 1,799,430 2.07 17.64 643,754 31,741,945
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26,135 1,762,936 1.50 17.89 467,555 31,538,925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,359 1,736,801 2.14 17.79 646,827 30,897,690
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1,700,442 0.01 18.00 1,800 30,607,956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11,024 1,700,342 0.65 17.96 197,991 30,538,142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,321 1,689,318 0.44 17.97 131,558 30,357,044
2020-08-19 2020-08-17 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -538,654 4,443,679 -10.81 22.75 -12,254,378 101,093,697
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,425 1,681,997 0.38 17.89 114,943 30,090,926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,993 1,675,572 2.32 17.49 664,498 29,305,754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,895 1,637,579 1.23 17.89 355,922 29,296,288
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1,617,684 0.05 17.99 13,169 29,102,135
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,105 1,616,952 0.25 17.99 73,849 29,088,966
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,989,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,836,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,989,000 1,989,000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,836,000 3,394,333 117.82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875,000 1,558,333 128.05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600,000 683,333 720.00
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,834 1,612,847 0.24 17.99 68,974 29,015,118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68,749 1,609,013 4.46 17.93 1,232,670 28,849,603
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1,540,264 0.01 18.00 3,474 27,724,752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24,000 44,000 120.00 13.35 320,400 587,400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16,806 16,806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-06-19 2020-06-17 4 RVMD Revolution Medicines, Inc.
Stock Option (Right to Buy)
A - Award 25,318 25,318
2020-06-19 2020-06-17 4 RVMD Revolution Medicines, Inc.
Common Stock
A - Award 7,234 7,234
2020-06-19 2020-06-18 4 RAPT RAPT Therapeutics, Inc.
Stock Option (right to buy)
A - Award 22,500 22,500
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Series D Preferred Stock
C - Conversion -151,515 0 -100.00
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Series C Preferred Stock
C - Conversion -416,666 0 -100.00
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -625,000 0 -100.00
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -3,500,000 0 -100.00
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
C - Conversion 151,515 4,768,181 3.28
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
C - Conversion 416,666 4,616,666 9.92
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
C - Conversion 625,000 4,200,000 17.48
2020-04-28 2020-04-28 4 ORIC Oric Pharmaceuticals, Inc.
Common Stock
C - Conversion 3,500,000 3,575,000 4,666.67
2020-04-27 2020-04-23 4 ORIC Oric Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 16,625 16,625
2020-04-23 3 ORIC Oric Pharmaceuticals, Inc.
Common Stock
150,000
2020-04-23 3 ORIC Oric Pharmaceuticals, Inc.
Common Stock
150,000
2020-04-23 3 ORIC Oric Pharmaceuticals, Inc.
Common Stock
150,000
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112,602 17,706,978 0.64 14.95 1,683,400 264,719,321
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123,728 17,594,376 0.71 14.38 1,779,209 253,007,127
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,587 17,470,648 0.08 12.41 181,025 216,810,742
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,850 17,456,061 0.09 12.40 184,140 216,455,156
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 17,441,211 0.68 12.26 1,447,501 213,829,247
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 17,323,144 0.69 12.53 1,479,380 217,058,994
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,416 17,205,077 0.01 12.49 30,176 214,891,412
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128,377 17,202,661 0.75 12.22 1,568,767 210,216,517
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170,387 17,074,284 1.01 11.63 1,981,601 198,573,923
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143,082 16,903,897 0.85 11.77 1,684,075 198,958,868
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148,464 16,760,815 0.89 11.59 1,720,698 194,257,846
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5,539 6,051,376 0.09 23.15 128,228 140,089,354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36,135 6,045,837 0.60 22.38 808,701 135,305,832
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,307 16,612,351 0.05 18.00 149,526 299,022,318
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,986 16,604,044 0.06 17.96 179,349 298,208,630
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38,758 16,594,058 0.23 17.99 697,256 298,527,103
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,124 16,555,300 0.09 17.90 252,820 296,339,870
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,800 16,541,176 0.23 17.91 676,998 296,252,462
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,896 16,503,376 0.21 17.91 607,077 295,575,464
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,751 16,469,480 0.02 18.00 67,518 296,450,640
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series C Preferred Stock
C - Conversion -99,758 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock
C - Conversion -2,740,043 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series A Preferred Stock
C - Conversion -5,137,583 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock
C - Conversion 7,977,384 7,977,384
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44,900 16,465,729 0.27 15.96 716,604 262,793,035
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 16,420,829 0.00 12.00 180 197,049,948
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,409 16,420,814 0.05 11.99 100,824 196,885,560
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C-2 Preferred Stock
C - Conversion -872,410 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C-2 Preferred Stock
C - Conversion -872,410 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -8,724,100 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -4,362,050 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -7,000,000 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -14,781,963 0 -100.00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 145,401 145,401
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 145,401 145,401
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 1,454,016 1,454,016
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 625,000 4,982,333 14.34 12.00 7,500,000 59,787,996
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 727,008 4,357,333 20.03
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 1,166,666 3,630,325 47.36
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 2,463,659 2,463,659
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100,000
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,087 16,412,405 0.01 11.86 24,752 194,651,123
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,300 16,410,318 0.01 12.00 27,600 196,923,816
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43,400 16,408,018 0.27 11.94 518,196 195,911,735
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,721 16,364,618 0.21 11.29 392,000 184,756,537
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,818 16,329,897 0.04 10.62 72,407 173,423,506
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 16,323,079 0.21 10.26 358,074 167,474,791
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,200 16,288,179 0.20 10.31 342,292 167,931,125
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 16,254,979 0.22 10.36 361,564 168,401,582
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 16,220,079 0.11 10.57 187,343 171,446,235
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 16,202,355 0.11 10.50 186,102 170,124,728
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 16,184,631 0.11 10.26 181,848 166,054,314
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 80,000 159,155 101.07 8.50 680,000 1,352,818
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 1,331,764 6,009,702 28.47 8.50 11,319,994 51,082,467
2019-08-09 2019-08-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 152 16,166,907 0.00 13.99 2,126 226,175,029
2019-08-09 2019-08-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12 16,166,755 0.00 13.98 168 226,011,235
2019-08-09 2019-08-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 224,500 16,166,743 1.41 14.00 3,143,000 226,334,402
2019-08-07 2019-08-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 310 15,942,243 0.00 13.96 4,328 222,553,712
2019-08-07 2019-08-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,824 15,941,933 0.04 13.98 81,400 222,814,021
2019-08-05 2019-08-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,782 15,936,109 0.01 13.97 24,898 222,660,909
2019-08-05 2019-08-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,600 15,934,327 0.02 13.98 36,346 222,749,144
2019-07-31 2019-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,855 15,931,727 0.06 13.91 123,195 221,650,152
2019-07-31 2019-07-29 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,201 15,922,872 0.12 13.58 260,727 216,213,494
2019-07-26 2019-07-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,059 15,903,671 0.19 13.59 408,634 216,200,865
2019-07-26 2019-07-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,753 15,873,612 0.19 13.37 411,294 212,295,274
2019-07-26 2019-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 29,054 15,842,859 0.18 13.51 392,502 214,027,519
2019-07-23 2019-07-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,760 15,813,805 0.19 13.35 410,535 211,057,367
2019-07-23 2019-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,760 15,783,045 0.20 13.54 416,337 213,623,514
2019-07-23 2019-07-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,222 15,752,285 0.04 13.99 87,043 220,366,591
2019-07-17 2019-07-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,900 15,746,063 0.02 13.86 54,055 218,245,157
2019-07-17 2019-07-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,188 15,742,163 0.10 13.69 221,547 215,445,669
2019-07-15 2019-07-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 21,014 15,725,975 0.13 13.88 291,765 218,344,155
2019-07-15 2019-07-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,870 15,704,961 0.07 13.87 150,752 217,805,822
2019-06-26 2019-06-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,240 15,694,091 0.08 13.78 168,650 216,242,602
2019-06-21 2019-06-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,763 15,681,851 0.02 14.03 52,789 219,992,847
2019-06-21 2019-06-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15,400 15,678,088 0.10 13.86 213,385 217,238,723
2019-06-21 2019-06-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15,214 15,662,688 0.10 13.91 211,674 217,916,544
2019-06-20 2019-06-19 4 GRTS Gritstone Oncology, Inc.
Stock Option (Right to Buy)
A - Award 8,570 8,570
2019-06-14 2019-06-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,760 15,647,474 0.07 14.00 150,687 219,133,485
2019-06-14 2019-06-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11,500 15,636,714 0.07 14.13 162,508 220,963,969
2019-06-14 2019-06-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,500 15,625,214 0.05 14.00 104,989 218,729,558
2019-06-11 2019-06-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,900 15,617,714 0.07 13.83 150,718 215,950,817
2019-06-11 2019-06-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 15,606,814 0.08 13.66 172,176 213,263,992
2019-06-06 2019-06-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 15,594,214 0.08 13.40 168,884 209,017,047
2019-06-06 2019-06-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 15,581,614 0.08 13.39 168,764 208,700,138
2019-05-22 2019-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 50,000 15,569,014 0.32 13.50 675,000 210,181,689
2019-05-17 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2019-05-13 2019-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,923 15,519,014 0.12 13.85 248,234 214,938,344
2019-05-09 2019-05-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 57,000 15,501,091 0.37 14.10 803,700 218,565,383
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -3,400,000 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -2,377,334 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series B Convertible Preferred Stock
C - Conversion -8,408,933 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series A Convertible Preferred Stock
C - Conversion -12,000,000 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 13,093,134 15,444,091 556.93
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,875,000 2,350,957 393.94 16.00 30,000,000 37,615,312
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 20,000 20,000 16.00 320,000 320,000
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-02 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Common Stock
U - Other -6,642,942 0 -100.00 5.85 -38,861,211
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series B Convertible Preferred Stock
C - Conversion -929,022 0 -100.00
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series A Convertible Preferred Stock
C - Conversion -2,173,912 0 -100.00
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Common Stock
C - Conversion 3,102,934 3,102,934
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series B Convertible Preferred Stock
C - Conversion -929,022 0 -100.00
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Series A Convertible Preferred Stock
C - Conversion -2,173,912 0 -100.00
2018-10-02 2018-10-02 4 GRTS Gritstone Oncology, Inc.
Common Stock
C - Conversion 3,102,934 3,102,934
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -20,000,000 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
C - Conversion -6,502,856 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -3,555,555 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -970,159 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8,333,333 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -11,000,000 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 4,666,888 4,677,939 42,230.46
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series C Preferred Stock
C - Conversion -470,427 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series C Preferred Stock
C - Conversion -427,660 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series B Preferred Stock
C - Conversion -875,087 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series A Preferred Stock
C - Conversion -1,767,676 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 470,427 470,427
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 427,660 3,070,423 16.18
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 875,087 2,642,763 49.50
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 1,767,676 1,767,676
2018-01-08 2018-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 12,500 12,500
2017-10-27 2017-10-27 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 2,681,000 2,681,000 4.10 10,992,100 10,992,100
2017-01-06 2017-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 10,000 10,000
2016-09-20 2016-09-20 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 800,000 800,000 6.25 5,000,000 5,000,000
2016-01-06 2016-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 9,300 9,300
2015-01-09 2015-01-07 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 9,300 9,300
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -428,134 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
X - Other 428,134 428,134
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock Warrant (right to buy)
X - Other -428,134 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -856,269 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series B Preferred Stock
C - Conversion -744,580 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series A Preferred Stock
C - Conversion -733,943 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 399,016 3,161,942 14.44 12.00 4,788,192 37,943,304
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 428,134 2,762,926 18.34
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 856,269 2,334,792 57.91
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 744,580 1,478,523 101.45
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 733,943 733,943
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)